<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01835912</url>
  </required_header>
  <id_info>
    <org_study_id>12-009</org_study_id>
    <nct_id>NCT01835912</nct_id>
  </id_info>
  <brief_title>Chronic Versus Acute Dosing of Sodium Citrate for Swimming 200m</brief_title>
  <official_title>Chronic vs. Acute Ingestion of Sodium Citrate: a Randomised Placebo Controlled Cross-over Trial for Swimming a 200 Metres in Well-trained Swimmers Age 13-17</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brock University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Brock University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ingestion of sodium citrate (Na-Cit), an alkalizing agent, increases extracellular pH via
      liver oxidation by decreasing [H+] and increasing bicarbonate concentration (HCO3-). Studies
      have confirmed that increasing extracellular pH promotes the efflux of La- and H+ from active
      muscles. This is due to an increase in activity of the pH sensitive monocarboxylate
      transporter as the gradient of intracellular versus extracellular H+ increases. Therefore,
      artificially inducing alkalosis prior to anaerobic exercise may reduce intracellular acidosis
      and increase the time to fatigue - defined as a decrease in force production with an
      increased perception of effort. The investigators will test the null hypothesis that sodium
      citrate ingestion (chronic and acute) will not have an effect on exercise performance
      compared to placebo.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Anaerobic glycolysis quickly provides adenosine triphosphate (ATP) for muscular contraction
      during high intensity, short duration exercise. The fast rate of glycolysis during anaerobic
      exercise results in pyruvate formation exceeding pyruvate oxidation resulting in a build up
      of lactic acid. Lactic acid dissociates quickly to lactate (La-) and hydrogen ion (H+) which
      causes a decrease in muscle and blood pH. The increase in H+ causes impaired release of
      calcium from the sarcoplasmic reticulum and calcium ion binding which inhibits the coupling
      of actin and myosin.

      Ingestion of sodium citrate (Na-Cit), an alkalizing agent, increases extracellular pH via
      liver oxidation by decreasing [H+] and increasing bicarbonate concentration (HCO3-). Studies
      have confirmed that increasing extracellular pH promotes the efflux of La- and H+ from active
      muscles. This is due to an increase in activity of the pH sensitive monocarboxylate
      transporter as the gradient of intracellular versus extracellular H+ increases. Therefore,
      artificially inducing alkalosis prior to anaerobic exercise may reduce intracellular acidosis
      and increase the time to fatigue - defined as a decrease in force production with an
      increased perception of effort. Furthermore, Cit- enters the cell through the Plasma Membrane
      Citrate Transporter and in the cell Cit- is involved in a number of processes: i)
      intermediary in the Krebs Cycle, ii) transports acetyl-Co-enzyme A (CoA)from the mitochondria
      to the cytosol for fatty-acid synthesis, iii) negative allosteric effector of
      phosphofructokinase, iv) anionic effect on membrane potential can cause a reduction in the
      contraction threshold.

      Researchers have studied sodium bicarbonate and Na-Cit as potential alkalizing agents. Na-Cit
      has been studied in few sports over a broad array of doses, times, and distances with
      inconclusive results. McNaughton et al. researched the optimal doses and durations for Na-Cit
      to be potentially beneficial to performance. They concluded that 0.3-0.5g/kg, 90-120 minutes
      prior to maximal effort are the optimal conditions for potential ergogenic effect. The only
      reported side effect was gastrointestinal (GI) discomfort in a 3 of the 8 subjects. However,
      it seems Na-Cit is handled better than the more commonly employed sodium bicarbonate.

      The investigators will test the null hypothesis that sodium citrate ingestion (chronic and
      acute) will not have an effect on exercise performance compared to placebo.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Actual">April 2013</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time</measure>
    <time_frame>once each 200m performance</time_frame>
    <description>time to complete 200 metre swimming performances in seconds
Participants chose type of swim stroke to swim a maximal effort 200 metre performance</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lactate</measure>
    <time_frame>3 min post performance</time_frame>
    <description>lactate measured at 3min post trial</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Rate of Perceived Exertion</measure>
    <time_frame>Rate of Perceived Exertion after each 200m swimming performance</time_frame>
    <description>Rate of perceived exertion (RPE) was recorded after each 200 metre swimming performance
RPE scale is from 6-20. Minimum = 6 (level of exertion equal to lying down) and Maximum = 20 (maximal perceived exertion)
Numbers reported are the average of the RPE recorded for all 10 participants.</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Alkalosis</condition>
  <arm_group>
    <arm_group_label>Flavoured water placebo for acute dosing</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>500 milliliters flavoured water (placebo for the acute dosing intervention of sodium citrate)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sodium Citrate Dihydrate Acute</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>dose: 0.5 g/kg of body mass dissolved in 500 milliliters of flavoured water</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Flavoured water placebo chronic dosing</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>500 milliliters flavoured water (placebo for the chronic dosing intervention of sodium citrate)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sodium Citrate Dihydrate Chronic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3 days of 0.1g/kg of body mass of sodium citrate and 4th day at 0.3 g/kg of body mass of sodium citrate in 500 milliliters of flavoured water</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sodium Citrate Dihydrate</intervention_name>
    <description>Dose sodium citrate dihydrate through 2 dosing protocols (Acute and Chronic)</description>
    <arm_group_label>Flavoured water placebo for acute dosing</arm_group_label>
    <arm_group_label>Sodium Citrate Dihydrate Acute</arm_group_label>
    <arm_group_label>Flavoured water placebo chronic dosing</arm_group_label>
    <arm_group_label>Sodium Citrate Dihydrate Chronic</arm_group_label>
    <other_name>CAS: 6132-04-3</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 13-17

          -  Male

          -  Regional, provincial and national level swimmers

        Exclusion Criteria:

          -  Females

          -  Level of swimming below regional level standards

          -  Caffeine before trials

          -  Chronic health concerns

          -  Health problems before or during the course of the trial
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nota Klentrou, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Brock University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Brock University</name>
      <address>
        <city>St. Catharines</city>
        <state>Ontario</state>
        <zip>l2s3a1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>July 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 10, 2013</study_first_submitted>
  <study_first_submitted_qc>April 18, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 19, 2013</study_first_posted>
  <results_first_submitted>March 19, 2014</results_first_submitted>
  <results_first_submitted_qc>July 23, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 24, 2014</results_first_posted>
  <last_update_submitted>July 23, 2014</last_update_submitted>
  <last_update_submitted_qc>July 23, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 24, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brock University</investigator_affiliation>
    <investigator_full_name>Colin Russell</investigator_full_name>
    <investigator_title>M.Sc. Researcher Brock University</investigator_title>
  </responsible_party>
  <keyword>performance</keyword>
  <keyword>speed</keyword>
  <keyword>exertion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alkalosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Citric Acid</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>All Study Participants</title>
          <description>Sodium Citrate Dihydrate: Dose sodium citrate dihydrate through 2 dosing protocols (Acute and Chronic) and their corresponding placebos.
4 arms: Acute, Acute Placebo, Chronic, Chronic Placebo
Acute: 0.5 g/kg of body mass of sodium citrate in 500 millilitres of flavoured water
Acute Placebo: 500 milliliters of flavoured water
Chronic: 3 days of 0.1 g/kg of body mass of sodium citrate and 4th day at 0.3 g/kg of body mass of sodium citrate in 500 millilitres of flavoured water
Chronic Placebo: 3 days of 500 millilitres of flavoured water and 4th day 500 millilitres of flavoured water</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Acute</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Acute Placebo</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Chronic</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Chronic Placebo</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>All Study Participants</title>
          <description>Acute: dose: 0.5 g/kg of body mass dissolved in 500 milliliters of flavoured water
Sodium Citrate Dihydrate: Dose sodium citrate dihydrate through 2 dosing protocols (Acute and Chronic)
Acute Placebo: 500 milliliters flavoured water (placebo for the acute dosing intervention of sodium citrate)
Chronic: 3 days of 0.1g/kg of body mass of sodium citrate and 4th day at 0.3 g/kg of body mass of sodium citrate in 500 milliliters of flavoured water
Sodium Citrate Dihydrate: Dose sodium citrate dihydrate through 2 dosing protocols (Acute and Chronic)
Chronic Placebo: 3 days of 500 milliliters flavoured water and the 4th day 500 milliliters flavoured water (placebo for the chronic dosing intervention of sodium citrate)</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>males</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Canada</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Time</title>
        <description>time to complete 200 metre swimming performances in seconds
Participants chose type of swim stroke to swim a maximal effort 200 metre performance</description>
        <time_frame>once each 200m performance</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Flavoured Water Placebo for Acute Dosing</title>
            <description>500 milliliters flavoured water (placebo for the acute dosing intervention of sodium citrate)</description>
          </group>
          <group group_id="O2">
            <title>Sodium Citrate Dihydrate Acute</title>
            <description>dose: 0.5 g/kg of body mass dissolved in 500 milliliters of flavoured water
Sodium Citrate Dihydrate: Dose sodium citrate dihydrate through 2 dosing protocols (Acute and Chronic)</description>
          </group>
          <group group_id="O3">
            <title>Flavoured Water Placebo for Chronic Dosing</title>
            <description>500 milliliters flavoured water (placebo for the chronic dosing intervention of sodium citrate)</description>
          </group>
          <group group_id="O4">
            <title>Sodium Citrate Dihydrate Chronic</title>
            <description>3 days of 0.1g/kg of body mass of sodium citrate and 4th day at 0.3 g/kg of body mass of sodium citrate in 500 milliliters of flavoured water
Sodium Citrate Dihydrate: Dose sodium citrate dihydrate through 2 dosing protocols (Acute and Chronic)</description>
          </group>
        </group_list>
        <measure>
          <title>Time</title>
          <description>time to complete 200 metre swimming performances in seconds
Participants chose type of swim stroke to swim a maximal effort 200 metre performance</description>
          <units>seconds</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="144.2" spread="4.7"/>
                    <measurement group_id="O2" value="145.3" spread="5.3"/>
                    <measurement group_id="O3" value="145.3" spread="5.4"/>
                    <measurement group_id="O4" value="144.8" spread="5.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Lactate</title>
        <description>lactate measured at 3min post trial</description>
        <time_frame>3 min post performance</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Flavoured Water Placebo for Acute Dosing</title>
            <description>500 milliliters flavoured water (placebo for the acute dosing intervention of sodium citrate)</description>
          </group>
          <group group_id="O2">
            <title>Sodium Citrate Dihydrate Acute</title>
            <description>dose: 0.5 g/kg of body mass dissolved in 500 milliliters of flavoured water
Sodium Citrate Dihydrate: Dose sodium citrate dihydrate through 2 dosing protocols (Acute and Chronic)</description>
          </group>
          <group group_id="O3">
            <title>Flavoured Water Placebo for Chronic Dosing</title>
            <description>500 milliliters flavoured water (placebo for the chronic dosing intervention of sodium citrate)</description>
          </group>
          <group group_id="O4">
            <title>Sodium Citrate Dihydrate Chronic</title>
            <description>3 days of 0.1g/kg of body mass of sodium citrate and 4th day at 0.3 g/kg of body mass of sodium citrate in 500 milliliters of flavoured water
Sodium Citrate Dihydrate: Dose sodium citrate dihydrate through 2 dosing protocols (Acute and Chronic)</description>
          </group>
        </group_list>
        <measure>
          <title>Lactate</title>
          <description>lactate measured at 3min post trial</description>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.8" spread="0.7"/>
                    <measurement group_id="O2" value="10.4" spread="1.3"/>
                    <measurement group_id="O3" value="9.5" spread="1.2"/>
                    <measurement group_id="O4" value="10.8" spread="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Rate of Perceived Exertion</title>
        <description>Rate of perceived exertion (RPE) was recorded after each 200 metre swimming performance
RPE scale is from 6-20. Minimum = 6 (level of exertion equal to lying down) and Maximum = 20 (maximal perceived exertion)
Numbers reported are the average of the RPE recorded for all 10 participants.</description>
        <time_frame>Rate of Perceived Exertion after each 200m swimming performance</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Flavoured Water Placebo for Acute Dosing</title>
            <description>500 milliliters flavoured water (placebo for the acute dosing intervention of sodium citrate)</description>
          </group>
          <group group_id="O2">
            <title>Sodium Citrate Dihydrate Acute</title>
            <description>dose: 0.5 g/kg of body mass dissolved in 500 milliliters of flavoured water
Sodium Citrate Dihydrate: Dose sodium citrate dihydrate through 2 dosing protocols (Acute and Chronic)</description>
          </group>
          <group group_id="O3">
            <title>Flavoured Water Placebo for Chronic Dosing</title>
            <description>500 milliliters flavoured water (placebo for the chronic dosing intervention of sodium citrate)</description>
          </group>
          <group group_id="O4">
            <title>Sodium Citrate Dihydrate Chronic</title>
            <description>3 days of 0.1g/kg of body mass of sodium citrate and 4th day at 0.3 g/kg of body mass of sodium citrate in 500 milliliters of flavoured water
Sodium Citrate Dihydrate: Dose sodium citrate dihydrate through 2 dosing protocols (Acute and Chronic)</description>
          </group>
        </group_list>
        <measure>
          <title>Rate of Perceived Exertion</title>
          <description>Rate of perceived exertion (RPE) was recorded after each 200 metre swimming performance
RPE scale is from 6-20. Minimum = 6 (level of exertion equal to lying down) and Maximum = 20 (maximal perceived exertion)
Numbers reported are the average of the RPE recorded for all 10 participants.</description>
          <units>units on a scale (6-20)</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.4" spread="0.6"/>
                    <measurement group_id="O2" value="16.1" spread="0.6"/>
                    <measurement group_id="O3" value="16.6" spread="0.3"/>
                    <measurement group_id="O4" value="17.1" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Flavoured Water Placebo for Acute Dosing</title>
          <description>500 milliliters flavoured water (placebo for the acute dosing intervention of sodium citrate)</description>
        </group>
        <group group_id="E2">
          <title>Sodium Citrate Dihydrate Acute</title>
          <description>dose: 0.5 g/kg of body mass dissolved in 500 milliliters of flavoured water
Sodium Citrate Dihydrate: Dose sodium citrate dihydrate through 2 dosing protocols (Acute and Chronic)</description>
        </group>
        <group group_id="E3">
          <title>Flavoured Water Placebo for Chronic Dosing</title>
          <description>500 milliliters flavoured water (placebo for the chronic dosing intervention of sodium citrate)</description>
        </group>
        <group group_id="E4">
          <title>Sodium Citrate Dihydrate Chronic</title>
          <description>3 days of 0.1g/kg of body mass of sodium citrate and 4th day at 0.3 g/kg of body mass of sodium citrate in 500 milliliters of flavoured water
Sodium Citrate Dihydrate: Dose sodium citrate dihydrate through 2 dosing protocols (Acute and Chronic)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Panagiota Klentrou</name_or_title>
      <organization>BrockU</organization>
      <phone>19056885550 ext 4538</phone>
      <email>nklentrou@brocku.ca</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

